Fenbendazole success story for a patient sent home to die from Esophageal Cancer (by Daylene Martinez Oct.2023)




According to Dr William Makis (source):

Patient: 93 year old man with esophageal cancer (distal esophagus), sent home on hospice to die.

Her dad took 3ml (300mg) of Safeguard (Merck) Fenbendazole once a day, 3 days on 4 days off, from July 30, 2023 until Oct.10, 2023 when he was declared cancer free on follow-up scans.

That’s 2.5 months on what would be considered a fairly low dose of Fenbendazole.

The liquid may absorb better than pills or powder.

Comments

Labels

Show more

Archive

Show more

Popular posts from this blog

Top Oncologist Blows Whistle: ‘Ivermectin Proven More Effective Than Chemotherapy’

Ivermectin and Fenbendazole: Treating Turbo Cancer - Dr William Makis

Fenbendazole Joe Tippens Protocol: A Step-by-Step Guide (2024)

Fenbendazole for Humans: Safety and Efficacy Examined

FENBENDAZOLE in Stage 4 Cancers - the 2021 Stanford University Case Series

Fenbendazole: Questions Answered, Things to Know, Useful Tips - Ben Fen

12 Types of Zinc Supplementation and Absorption 2024

Fenbendazole Cancer Success Stories and Treatment Testimonials: Case Series Compilation (2024)

FENBENDAZOLE and CANCER - at least 12 Anti-Cancer Mechanisms of Action - Dr William Makis (2024)

I-PREVENT CANCER protocol: An Evidence-Based Guide to Cancer Prevention (2024 Edition)